37 related articles for article (PubMed ID: 216409)
21. Receptors and receptor mechanisms of endogenous platelet stimulatory and inhibitory mediators.
MacIntyre DE; Bushfield M; MacMillan LJ; Moffat KJ; Murdoch FA; Thomson A; Rossi AG; McNicol A
Agents Actions Suppl; 1986; 20():45-62. PubMed ID: 3028106
[No Abstract] [Full Text] [Related]
22. Platelet-endothelial cell interactions. Metabolic maps of structures and actions of prostaglandins, prostacyclin, thromboxane and cyclic AMP.
Nalbandian RM; Henry RL
Semin Thromb Hemost; 1978; 5(2):87-111. PubMed ID: 216078
[No Abstract] [Full Text] [Related]
23. Biology and therapeutic potential of prostacyclin.
Moncada S
Stroke; 1983; 14(2):157-68. PubMed ID: 6301111
[No Abstract] [Full Text] [Related]
24. Prostaglandins and coronary circulation.
Vapaatalo H
Acta Med Scand Suppl; 1985; 694():45-54. PubMed ID: 3890471
[No Abstract] [Full Text] [Related]
25. Prostacyclin.
Vane JR; Moncada S
Ciba Found Symp; 1980; 71():79-97. PubMed ID: 6245837
[No Abstract] [Full Text] [Related]
26. Anti-platelet drugs: rationale for use.
Hardisty RM
Bibl Haematol; 1977; 44():181-7. PubMed ID: 216344
[No Abstract] [Full Text] [Related]
27. The effect of ethanol on platelet function and vascular prostanoids.
Mikhailidis DP; Barradas MA; Jeremy JY
Alcohol; 1990; 7(2):171-80. PubMed ID: 2109617
[TBL] [Abstract][Full Text] [Related]
28. Common pathways of membrane reactivity after stimulation of platelets by different agents.
Lüscher EF; Massini P
Ciba Found Symp; 1975; 35():5-21. PubMed ID: 179771
[No Abstract] [Full Text] [Related]
29. Independence of the cyclic AMP-lowering activity of thromboxane A2 from the platelet release reaction.
Gorman RR; Wierenga W; Miller OV
Biochim Biophys Acta; 1979 Jan; 572(1):95-104. PubMed ID: 216409
[No Abstract] [Full Text] [Related]
30. Prostaglandins and thromboxanes: "middlemen" modulating platelet function in hemostasis and thrombosis.
Gerrard JM; White JG
Prog Hemost Thromb; 1978; 4():87-125. PubMed ID: 213813
[No Abstract] [Full Text] [Related]
31. Pharmacological interactions between prostacyclin and thromboxanes.
Whittle BJ; Moncada S
Br Med Bull; 1983 Jul; 39(3):232-8. PubMed ID: 6313114
[No Abstract] [Full Text] [Related]
32. Biological actions of prostacyclin and its pharmacological use in platelet studies.
Moncada S; Whittle BJ
Adv Exp Med Biol; 1985; 192():337-58. PubMed ID: 3010671
[No Abstract] [Full Text] [Related]
33. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
Smith JB; Araki H; Lefer AM
Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
[TBL] [Abstract][Full Text] [Related]
34. The role of prostaglandins in platelet function.
Marcus AJ
Prog Hematol; 1979; 11():147-71. PubMed ID: 230534
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
